RVL Pharmaceuticals plc Lessee, Operating Lease, Liability, to be Paid, Year Two
RVL Pharmaceuticals plc had Lessee, Operating Lease, Liability, to be Paid, Year Two of $93.00 thousand as of 2022-12-31, per its 10-K filed 2023-03-20.
Discontinued › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo · last filed 2023-03-20
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Two $93.00K.
- 2021-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Two $491.00K.
- 2020-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Two $647.00K; Lessee, Operating Lease, Liability, to be Paid, Year Two as first filed $955.00K.
- 2019-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Two $1.89M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year Two | Lessee, Operating Lease, Liability, to be Paid, Year Two as first filed |
|---|---|---|
| 2022-12-31 | $93.00K 10-K · filed 2023-03-20 | |
| 2021-12-31 | $491.00K 10-K · filed 2022-03-30 | |
| 2020-12-31 | $647.00K 8-K · filed 2021-09-08 | $955.00K 10-K · filed 2021-03-30 |
| 2019-12-31 | $1.89M 10-K · filed 2020-03-19 | |
| 2019-09-30 | $2.33M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $2.49M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $2.30M 10-Q · filed 2019-05-09 |